Академический Документы
Профессиональный Документы
Культура Документы
TABLE 18-3
Cytomegalovirus Prophylaxis Protocol Based on Recipient and Donor CMV Status
RECIPIENT CMV NEGATIVE RECIPIENT CMV
POSITIVE
Donor CMV Low risk: IV ganciclovir or oral Moderate risk;
negative valganciclovir x 6 weeks reactivation reuipient strain
CMV A IV gancidlovir or
oral valganddovir x 12
weeks
Droior CMV Highest risk active new CMV Moderate risk:
positive infection during reactivation recipient strain
immunosuppression V ganciclovir or new infection with donor
or PO valganciclovir x 12 weeks strain IV gancidovir or oral
plus full course CMV immune valganadovir 12 weeks plus
globulin CytoGam 150 mg/kg V on füll course CMV immune
days 0, 14, 28, 42, 56 CytoGam 100 globulin
mg/kg V on days 84 and 112